Recovery of menstruation after long-term chemotherapy and endocrine therapy in pre-menopausal patients with breast cancer

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 4, 2011, Pages 615-620

  Sakurai, Kenichi ^a   Enomoto, Katsuhisa ^a   Amano, Sadao ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Breast cancer; Chemotherapy; LH RH agonist; Menstruation recovery; Pre menopausal patients

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; GOSERELIN; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUATION DISORDER; MULTIPLE CYCLE TREATMENT; PREMENOPAUSE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; CYTARABINE; EPIRUBICIN; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; MENSTRUATION; MIDDLE AGED; PREMENOPAUSE; TAMOXIFEN;

EID: 79954448641     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0894-8     Document Type: Article

References (22)

1. Beatson GW (1895) On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet ii:104-107, 162-165
2. J Bines DM Oleske MA Cobeleigh 1996 Ovarian function in premenopausal woman treated with adjuvant chemotherapy for breast cancer J Clin Oncol 14 1718 1729 8622093 1:CAS:528:DyaK28XjtFKitro%3D (Pubitemid 26134232)
3. RM Chapman 1982 Effect of cytotoxic therapy on sexuality and gonadal function Semin Oncol 9 84 94 6176028 1:STN:280:DyaL387ns1aqsA%3D%3D (Pubitemid 12116289)
4. RM Chapman SB Sutcliffe 1981 Protection of ovarian function by oral contraceptives in woman receiving chemotherapy for Hodgkin's Disease Blood 58 849 851 7272513 1:STN:280:DyaL38%2FgtFShsg%3D%3D (Pubitemid 11015846)
5. M Colleoni S Gelber A Goldhirsch, et al. 2006 Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: international breast cancer study group trial 13-93 J Clin Oncol 24 1332 1341 16505417 10.1200/JCO.2005.03.0783 1:CAS:528:DC%2BD28Xjs1Ogtrc%3D (Pubitemid 46621995)
6. NE Davidson AM O'Neill AM Vukov CK Osborne S Martino DR White MD Abeloff 1999 Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101(E5188) J Clin Oncol 23 5973 5982 10.1200/JCO.2005.05.551
7. Early Breast Cancer Trialists' Collaborative Group 2005 Effect of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials Lancet 365 1687 1717 10.1016/S0140-6736(05)66544-0 (Pubitemid 40719106)
8. MN Fornier S Modi KS Panageas L Norton C Hudis 2005 Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane Cancer 104 1575 1579 16134178 10.1002/cncr.21385 1:CAS:528:DC%2BD2MXhtF2nt73K (Pubitemid 41437419)
9. IC Henderson DA Berry GD Demetri CT Cirrincione LJ Goldstein S Martino JN Ingle MR Cooper DF Hayes KH Tkaczuk G Fleming JF Holland DB Duggan JT Carpenter E Frei III RL Schilsky WC Wood HB Muss L Norton 2003 Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer J Clin Oncol 21 976 983 12637460 10.1200/JCO.2003.02.063 1:CAS:528:DC%2BD2cXpsVGqs7c%3D (Pubitemid 46594124)
10. International Breast Cancer Study Group (IBCSG) 2003 Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial J Natl Cancer Inst 95 1833 1846
11. H Koyama T Wada Y Nishizawa T Iwanaga Y Aoki T Terasawa G Kosaki T Yamamoto A Wada 1977 Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer Cancer 39 1403 1409 851940 10.1002/1097-0142(197704)39:4<1403::AID-CNCR2820390408>3.0.CO;2-8 1:STN:280:DyaE2s7lvFOhtQ%3D%3D (Pubitemid 8108291)
12. M Martin T Pienkowski J Mackey, et al. 2005 Adjuvant docetaxel for node-positive breast cancer N Engl J Med 352 2302 2313 15930421 10.1056/NEJMoa043681 1:CAS:528:DC%2BD2MXksl2lt7c%3D (Pubitemid 40740554)
13. M Matsumoto M Miyauchi N Yamamoto T Shishikura N Imanaka 2000 Investigation of menstruation recovery after LH-RH agonist therapy for premenopausal patients with breast cancer Breast Cancer 7 237 240 11029804 10.1007/BF02967466 1:STN:280:DC%2BD3M3mvFKqsw%3D%3D
14. JL Pater WR Parulekar 2003 Ovarian ablation as adjuvant therapy for premenopausal women with breast cancer-another step forward J Natl Cancer Inst 95 1811 1812 14679143 (Pubitemid 38054674)
15. B Pereyra Pacheco JM Méndez Ribas G Milone I Fernández R Kvicala T Mila A Di Noto O Contreras Ortiz S Pavlovsky, et al. 2001 Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: a preliminary report Gynecol Oncol 81 391 397 11371127 10.1006/gyno.2001.6181 1:STN:280:DC%2BD3M3nslOmtg%3D%3D (Pubitemid 32494652)
16. LM Reyno MN Levine P Skingley A Arnold H Abu Zahra 1992 Chemotherapy induced amenorrhea in a randomized trial of adjuvant chemotherapy duration in breast cancer Eur J Cancer 29 21 23 10.1016/0959-8049(93)90569-2
17. T Saarto C Blomqvist C Ehnholm MR Taskinen I Elomaa 1996 Effects of chemotherapy-induced castration on serum lipids and apoproteins in premenopausal women with node-positive breast cancer J Clin Endocrinol Metab 81 4453 4457 8954058 10.1210/jc.81.12.4453 1:CAS:528:DyaK28XnsVOhs7c%3D (Pubitemid 26412060)
18. R Sutton AU Buzdar GN Hortobagyi 1990 Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients Cancer 65 847 850 2297653 10.1002/1097-0142(19900215)65:4<847::AID-CNCR2820650402>3.0.CO;2-A 1:STN:280:DyaK3c7isVWnsA%3D%3D (Pubitemid 20063482)
19. YL Tham K Sexton H Weiss R Elledge LC Friedman R Kramer 2007 The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane Am J Clin Oncol 30 126 132 17414460 10.1097/01.coc.0000251398.57630.4f 1:CAS:528:DC%2BD2sXltFWjsLc%3D (Pubitemid 46573245)
20. L Vehmanen T Saarto I Elomaa P Mäkelä M Välimäki C Blomqvist 2001 Long term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment Eur J Cancer 37 2373 2378 11720830 10.1016/S0959-8049(01)00317-3 1:CAS:528:DC%2BD3MXosFKgtLY%3D (Pubitemid 33097473)
21. JM Walshe N Denduluri SM Swain 2006 Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer J Clin Oncol 24 5769 5779 17130515 10.1200/JCO.2006.07.2793 1:CAS:528:DC%2BD2sXhtVChsLY%3D (Pubitemid 46646480)
22. MA Weitzer J Moncello PB Jacobsen S Minton 2002 A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer J Pain Symptom Manage 23 337 345 10.1016/S0885-3924(02)00379- 2 (Pubitemid 34462946)